Abstract |
The copper(II) complex A0 induces a type of non-apoptotic cell death also known as paraptosis. Paraptosis involves extensive endoplasmic reticulum vacuolization in the absence of caspase activation. A wide panel of human cancer cell lines was used to demonstrate differences in cytotoxicity by the paraptosis-inducing drug A0 and the metal-based pro-apoptotic drug cisplatin. Gene expression profiling of the human fibrosarcoma HT1080 cells showed that, while cisplatin induced p53 targets, A0 up-regulated genes involved in the unfolded protein response (UPR) and response to heavy metals. The cytotoxic effects of A0 were associated with inhibition of the ubiquitin- proteasome system and accumulation of ubiquitinylated proteins, in a manner dependent on protein synthesis. Cycloheximide inhibited the accumulation of ubiquitinylated proteins and hampered A0-induced cell death process. The occurrence of the UPR during A0-induced death process was shown by the increased abundance of spliced XBP1 mRNA, transient eIF2alpha phosphorylation, and a series of downstream events, including attenuation of global protein synthesis and increased expression of ATF4, CHOP, BIP, and GADD34. Mouse embryonic fibroblasts expressing a mutant eIF2alpha, which could not be phosphorylated, were more resistant to A0 than wild type cells, pointing to a pro-death role of eIF2alpha phosphorylation. A0 may thus represent the prototypical member of a new class of compounds that cause paraptotic cell death via mechanisms involving eIF2alpha phosphorylation and the UPR.
|
Authors | Saverio Tardito, Claudio Isella, Enzo Medico, Luciano Marchiò, Elena Bevilacqua, Maria Hatzoglou, Ovidio Bussolati, Renata Franchi-Gazzola |
Journal | The Journal of biological chemistry
(J Biol Chem)
Vol. 284
Issue 36
Pg. 24306-19
(Sep 04 2009)
ISSN: 0021-9258 [Print] United States |
PMID | 19561079
(Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Antineoplastic Agents
- Neoplasm Proteins
- Organometallic Compounds
- RNA, Messenger
- Ubiquitin
- Copper
- Proteasome Endopeptidase Complex
- Cisplatin
|
Topics |
- Animals
- Antineoplastic Agents
(pharmacology, therapeutic use)
- Apoptosis
(drug effects)
- Caco-2 Cells
- Cisplatin
(pharmacology)
- Copper
(pharmacology, therapeutic use)
- Drug Screening Assays, Antitumor
- Endoplasmic Reticulum
(genetics, metabolism)
- Gene Expression Profiling
- Gene Expression Regulation, Neoplastic
(drug effects)
- HeLa Cells
- Humans
- Mice
- Neoplasm Proteins
(biosynthesis, genetics)
- Neoplasms
(drug therapy, genetics, metabolism)
- Organometallic Compounds
(pharmacology, therapeutic use)
- Proteasome Endopeptidase Complex
(genetics, metabolism)
- Protein Folding
(drug effects)
- RNA, Messenger
(genetics, metabolism)
- Stress, Physiological
(drug effects)
- Ubiquitin
(genetics, metabolism)
- Ubiquitination
(drug effects)
|